InsidersTradesSigma
Track the 휴네시온 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 휴네시온 has recorded 2 reports. Market capitalisation: €24.8bn. The latest transaction was disclosed on 21 April 2026 (Sale). Among the most active insiders: 심재중. Every trade is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€26,220
2 ops.
Sell Volume
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 341 of 29,063 companies
86.6
score / 100
Value96
Quality78
FCF yld24%
Earn yld22%
EV/EBITDA3.8x
ROE12%
Gross mgn48%
Net mgn15%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 April 2026
Acerca de 휴네시온
휴네시온 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el sector médico.